The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
In January 2022, Garutadustat, the innovative, potentially best-in-class, oral PHD inhibitor was nominated as a preclinical ...
The analysis, conducted with EpistemicGPT and the Epistemic Knowledge Graph , underscores a critical pivot in pharmaceutical decision-making. Mapping over ten years of trial outcomes, Epistemic AI ...
Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...
Oversubscribed GBP2.5M seed round led by Ahren Innovation Capital -- Strategic collaboration with o2h to progress drug discovery programme CAMBRIDGE, England--(BUSINESS WIRE)--January 12, 2026-- ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Phase III is intended to generate meaningful biological data on potential drug compounds prioritized by YuvaBio’s classifier, which applies proprietary machine-learning methods to identify candidates ...
Avinasi Labs Enables a New Funding & Revenue Model for Clinical Stage Assets via DeLong Protocol SAN FRANCISCO, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — Avinasi Labs, an AI-native ...
The wide range of chromatographic techniques share one common aim: to separate a material into its components. A material, your sample, is dissolved in a solvent, called the mobile phase. This mixture ...
The University's Anticancer Discovery from Pets to People has found success with a new drug that has treated cancer in pets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback